• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti Events, LLC's Virtual August Micro-Cap Conference

    8/15/23 10:20:00 AM ET
    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ANEB alert in real time by email

    NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

    Sidoti & Company, LLC, Monday, August 14, 2023, Press release picture

    Presentation Schedule

    *All Times EST

    Wednesday, August 16, 2023 (Day 1)

    8:30-9:00

    Ohmyhome Ltd. (OMH)

    Hookipa Pharma Inc. (HOOK)

    *****

    9:15-9:45

    Loop Industries (LOOP)

    Zomedica Inc (ZOM)

    LEE Enterprises, Inc. (LEE)

    10:00-10:30

    Mativ Holdings, Inc. (MATV)

    DLH Holdings (DLHC)

    T2 Biosystems, Inc. (TTOO)

    10:45-11:15

    Near Intelligence (NIR)

    Surmodics Inc. (SRDX)

    L.B. Foster Company (FSTR)

    11:30-12:00

    IDACORP, Inc (IDA)

    Harvard Bioscience (HBIO)

    Citizens, Inc. (CIA)

    12:15-12:45

    Independence Contract Drilling (ICD)

    Personalis (PSNL)

    Silvercrest Asset Management Group Inc. (SAMG)

    1:00-1:30

    Ideal Power (IPWR)

    Anebulo Pharmaceuticals (ANEB)

    GEE Group (JOB)

    1:45-2:15

    Powell Industries, Inc. (POWL)

    MAIA Biotechnology, Inc. (MAIA)

    Rocky Mountain Chocolate (RMCF)

    2:30-3:00

    Innovative Solutions & Support (ISSC)

    Hillstream BioPharma, Inc. (HILS)

    Super League Gaming, Inc (SLGG)

    3:15-3:45

    Unisys Corporation (UIS)

    Markforged (MKFG)

    CaliberCos Inc. (CWD)

    4:00-4:30

    Sonim Technologies (SONM)

    KLX Energy Services Holdings (KLXE)

    Comstock Inc (LODE)

    1x1s Only

    (16th)

    DevvStream Inc. (DSTRF)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Paysign, Inc. (PAYS)

    *****

    *****

    *****

    *All Times EST

    Thursday, August 17, 2023 (Day 2)

    8:30-9:00

    *****

    AGBA Group (AGBA)

    *****

    9:15-9:45

    MtronPTI (MPTI)

    The Real Brokerage Inc (REAX)

    Splash Beverage Group (SBEV)

    10:00-10:30

    CLIQ Digital AG (CLIQ)

    LifeMD (LFMD)

    Mistras Group (MG)

    10:45-11:15

    Innovative Eyewear, Inc. (LUCY)

    CareCloud (CCLD)

    Granite Construction Inc. (GVA)

    11:30-12:00

    Shapeways (SHPW)

    Processa Pharmaceuticals (PCSA)

    Landsea Homes (LSEA)

    12:15-12:45

    *****

    Modular Medical (MODD)

    Sidus Space (SIDU)

    1:00-1:30

    Daktronics (DAKT)

    Kala Pharmaceuticals (KALA)

    Terran Orbital (LLAP)

    1:45-2:15

    SOBR Safe Inc. (SOBR)

    Xcel Brands (XELB)

    SYLA Technologies (SYT)

    2:30-3:00

    Intellicheck (IDN)

    Alpha Teknova, Inc. (TKNO)

    ClearOne, Inc. (CLRO)

    3:15-3:45

    AudioEye Inc (AEYE)

    Quince Therapeutics (QNCX)

    Astra Space (ASTR)

    4:00-4:30

    Iteris, Inc. (ITI)

    *****

    ARC Document Solutions (ARC)

    1x1s Only

    (17th)

    Hall of Fame Resort & Entertainment Co. (HOFV)

    Kelly Services, Inc. (KELYA)

    Paysign, Inc. (PAYS)

    Tennant Company (TNC)

    *****

    *****

    About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
    In 2023, Sidoti & Company, LLC (www.sidoti.com) formed a sister company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the nearly 25 years of experience Sidoti had as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 160 equities of which around 40 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Events is a leading provider of corporate access through the eight investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Event's benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with 1,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti Events, LLC and Sidoti & Company, LLC



    View source version on accesswire.com:
    https://www.accesswire.com/774189/Sidoti-Events-LLCs-Virtual-August-Micro-Cap-Conference

    Get the next $ANEB alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ANEB
    $DLHC
    $HBIO
    $HOOK

    CompanyDatePrice TargetRatingAnalyst
    Personalis Inc.
    $PSNL
    5/15/2025$6.00Buy
    Guggenheim
    Harvard Bioscience Inc.
    $HBIO
    4/9/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    IDACORP Inc.
    $IDA
    4/2/2025Hold → Buy
    Jefferies
    Mativ Holdings Inc.
    $MATV
    3/24/2025$15.50 → $10.00Hold → Buy
    Stifel
    Personalis Inc.
    $PSNL
    3/17/2025$8.00Buy
    Canaccord Genuity
    Surmodics Inc.
    $SRDX
    3/7/2025$43.00Hold → Buy
    Lake Street
    IDACORP Inc.
    $IDA
    1/23/2025Neutral → Buy
    Guggenheim
    HOOKIPA Pharma Inc.
    $HOOK
    12/20/2024$48.00 → $2.00Outperform → Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Ritrievi Kimberly E

      4 - Mativ Holdings, Inc. (0001000623) (Issuer)

      7/2/25 6:34:50 PM ET
      $MATV
      Paper
      Basic Materials
    • Director Levi Marco was granted 18,328 shares, increasing direct ownership by 41% to 62,700 units (SEC Form 4)

      4 - Mativ Holdings, Inc. (0001000623) (Issuer)

      7/2/25 6:34:11 PM ET
      $MATV
      Paper
      Basic Materials
    • Director Stipancich John K was granted 18,328 shares, increasing direct ownership by 114% to 34,441 units (SEC Form 4)

      4 - Mativ Holdings, Inc. (0001000623) (Issuer)

      7/2/25 6:33:38 PM ET
      $MATV
      Paper
      Basic Materials

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Guggenheim initiated coverage on Personalis with a new price target

      Guggenheim initiated coverage of Personalis with a rating of Buy and set a new price target of $6.00

      5/15/25 8:13:23 AM ET
      $PSNL
      Medical Specialities
      Health Care
    • Harvard Biosci downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Harvard Biosci from Overweight to Sector Weight

      4/9/25 8:35:36 AM ET
      $HBIO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • IdaCorp upgraded by Jefferies

      Jefferies upgraded IdaCorp from Hold to Buy

      4/2/25 7:48:26 AM ET
      $IDA
      Electric Utilities: Central
      Utilities

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sonim Technologies Special Committee Determines Latest Orbic Proposal to be Inferior to Social Mobile Transaction Amidst Ongoing Strategic Review

      Orbic proposal remains conditional, uncertain, and unlikely to maximize value for Sonim stockholdersSan Diego, California--(Newsfile Corp. - July 2, 2025) - Sonim Technologies (NASDAQ:SONM) today announced that its Special Committee of the Board of Directors (the "Special Committee") has considered, with advice from its financial advisor and legal counsel, the unsolicited, non-binding proposal from Orbic North America, LLC ("Orbic") dated June 26, 2025, and has determined it to be inferior to the previously announced Letter of Intent (the "Social Mobile LOI") between Sonim and Social Mobile for the sale of substantially all of Sonim's operating assets. The Special Committee remains committed

      7/2/25 4:17:00 PM ET
      $SONM
      Telecommunications Equipment
      Utilities
    • Idaho Power's 20-year Energy Plan Calls for Significant Investment in Energy Resources to Meet Projected Growth

      Idaho Power Company (Idaho Power), a wholly owned subsidiary of IDACORP, Inc. (NYSE:IDA), has released its latest long-range energy plan, which forecasts unprecedented growth in energy demand and lays out the preferred options for serving customers. The 2025 Integrated Resource Plan was filed with state regulators Friday. It shows that the company needs to add significant energy resources, transmission, battery storage, and energy efficiency. The public utility commissions in Idaho and Oregon will set a schedule for public review and comment before deciding to acknowledge the plan. "The IRP is a really detailed analysis of how we are going to continue serving our customers with safe, re

      7/1/25 1:00:00 PM ET
      $IDA
      Electric Utilities: Central
      Utilities
    • MAIA Biotechnology to Present Two Posters Featuring Cancer Telomere-Targeting Agents at FEBS 2025 Congress

      MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced two upcoming poster presentations at the 49th Federation of European Biochemical Societies (FEBS) 2025 Congress, hosted by the Turkish Biochemical Society, to be held July 5-9, 2025, in Istanbul, Turkey. The poster presentations highlight MAIA's lead telomere-targeting agent and next-generation treatments. The first presentation will be delivered by MAIA Scientific Advisory Board member, Z. Gunnur Dikmen, M.D., Ph.D., Hacettepe University, Faculty of Medicine, Department of Biochemistry in Ankara, Turkey. Poster

      7/1/25 9:00:00 AM ET
      $MAIA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by HOOKIPA Pharma Inc.

      SC 13G/A - HOOKIPA Pharma Inc. (0001760542) (Subject)

      11/14/24 6:07:08 PM ET
      $HOOK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Surmodics Inc.

      SC 13G/A - SURMODICS INC (0000924717) (Subject)

      11/14/24 3:36:00 PM ET
      $SRDX
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by IDACORP Inc.

      SC 13G/A - IDACORP INC (0001057877) (Subject)

      11/14/24 1:28:29 PM ET
      $IDA
      Electric Utilities: Central
      Utilities

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Mink Brook Asset Management Llc bought $291,844 worth of shares (53,080 units at $5.50) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      6/27/25 5:32:03 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • Large owner Mink Brook Asset Management Llc bought $61,743 worth of shares (11,248 units at $5.49) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      6/25/25 5:15:37 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary
    • Large owner Mink Brook Asset Management Llc bought $132,569 worth of shares (24,311 units at $5.45) (SEC Form 4)

      4 - DLH Holdings Corp. (0000785557) (Issuer)

      6/20/25 4:33:34 PM ET
      $DLHC
      Professional Services
      Consumer Discretionary

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    SEC Filings

    See more
    • SEC Form 424B5 filed by Loop Industries Inc.

      424B5 - Loop Industries, Inc. (0001504678) (Filer)

      7/3/25 5:08:37 PM ET
      $LOOP
      Major Chemicals
      Industrials
    • Loop Industries Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

      8-K - Loop Industries, Inc. (0001504678) (Filer)

      7/3/25 5:04:41 PM ET
      $LOOP
      Major Chemicals
      Industrials
    • SEC Form DEFM14A filed by HOOKIPA Pharma Inc.

      DEFM14A - HOOKIPA Pharma Inc. (0001760542) (Filer)

      7/3/25 3:04:10 PM ET
      $HOOK
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Leadership Updates

    Live Leadership Updates

    See more
    • MAIA Biotechnology Welcomes Leading Hepatocellular Carcinoma Clinician-Scientists to Scientific Advisory Board

      Planning for Phase 2 clinical trial in hepatocellular carcinoma (HCC) underway MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced the appointment of two prominent oncologists to its Scientific Advisory Board (SAB), Claudia Fulgenzi, MD, and David J. Pinato, MD, MRCP (UK), PhD. Both are specialists in hepatocellular carcinoma (HCC), a tumor type to be studied in future clinical trials of MAIA's lead candidate ateganosine (THIO) sequenced with a checkpoint inhibitor. As SAB members they will advise MAIA on designs and protocols for its company sponsored trial (C

      6/24/25 8:15:00 AM ET
      $MAIA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Harvard Bioscience Appoints John Duke to Board of Directors

      HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company") today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating and governance committees. The Company also announced that Katherine Eade has been named Lead Independent Director of the Company's board of directors. "We are pleased to welcome John to Harvard Bioscience's board," said Katherine Eade, Lead Independent Director. "John brings deep experience in life science tools and business execution and has a track record of driving growth and operational excellence." Jim Green, President and CEO, sa

      6/2/25 4:57:22 PM ET
      $HBIO
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025

      Poster highlights potential predictive biomarker for therapeutic response in advanced non-small cell lung cancer (NSCLC)   MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract detailing a potential predictive biomarker for THIO treatment was selected for poster presentation at the European Lung Cancer Congress 2025 (ELCC 2025) taking place, March 26-29, in Paris, France. ELCC is a program of the European Society for Medical Oncology (ESMO). "We are proud to join ELCC 2025, a premier conference focused directly on the science of thoracic oncology," said V

      3/25/25 8:46:00 AM ET
      $MAIA
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ANEB
    $DLHC
    $HBIO
    $HOOK
    Financials

    Live finance-specific insights

    See more
    • Idaho Power's 20-year Energy Plan Calls for Significant Investment in Energy Resources to Meet Projected Growth

      Idaho Power Company (Idaho Power), a wholly owned subsidiary of IDACORP, Inc. (NYSE:IDA), has released its latest long-range energy plan, which forecasts unprecedented growth in energy demand and lays out the preferred options for serving customers. The 2025 Integrated Resource Plan was filed with state regulators Friday. It shows that the company needs to add significant energy resources, transmission, battery storage, and energy efficiency. The public utility commissions in Idaho and Oregon will set a schedule for public review and comment before deciding to acknowledge the plan. "The IRP is a really detailed analysis of how we are going to continue serving our customers with safe, re

      7/1/25 1:00:00 PM ET
      $IDA
      Electric Utilities: Central
      Utilities
    • Ideal Power Reports First Quarter 2025 Financial Results

      AUSTIN, Texas, May 15, 2025 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reports results for its first quarter ended March 31, 2025. "We had a strong start to the year as we completed SSCB prototypes related to our first design win three months ahead of schedule. We expect industrial markets, particularly the SSCB market, to be the earliest source of our initial sales ramp starting in the second half of this year. In addition, based on positive feedback from Stellantis, we expect to not only continue advancing

      5/15/25 9:20:00 AM ET
      $IPWR
      Semiconductors
      Technology
    • Innovative Solutions & Support Reports Second Quarter 2025 Results

      Innovative Solutions & Support, Inc. (NASDAQ:ISSC) ("IS&S" or the "Company"), a leading provider of advanced avionic solutions for commercial, business aviation and military markets, today reported fiscal second quarter financial results for the three-month period ended March 31, 2025. SECOND QUARTER 2025 HIGHLIGHTS (all comparisons versus the prior year period unless otherwise noted) Net revenue of $21.9 million, +104% Gross profit of $11.3 million; gross margin of 51.4% Net Income of $5.3 million, or $.30 per diluted share Adjusted EBITDA(1) of $7.7 million, +219 % Ratio of net debt to trailing twelve-month Adjusted EBITDA of 1.4x as of March 31, 2025 (1)   Adjusted E

      5/14/25 4:30:00 PM ET
      $ISSC
      EDP Services
      Technology